Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance
Go back to Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance| (NASDAQ: ORGO) | Delayed: 1.60 -0.11 (6.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.68 | 52 Week Low | $ | |||
| Day High | $1.68 | P/E | N/A | |||
| Day Low | $1.57 | EPS | $ | |||
| Volume | 979,710 | |||||

